LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

Missense mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's disease (PD), and common genetic variation in LRRK2 modifies susceptibility to Crohn's disease and leprosy. High levels of LRRK2 expression in peripheral monocytes and macrophages suggest a role for LRR...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Moehle, Mark S., Webber, Philip J., Tse, Tonia, Sukar, Nour, Standaert, David G., DeSilva, Tara M., Cowell, Rita M., West, Andrew B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Society for Neuroscience 2012
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532034/
https://ncbi.nlm.nih.gov/pubmed/22302802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.5601-11.2012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi